Progesterone Alleviates Neural Behavioral Deficits and Demyelination with Reduced Degeneration of Oligodendroglial Cells in Cuprizone-Induced Mice

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Ye, Jian Ning ^a   Chen, Xing Shu ^a   Su, Le ^a   Liu, Yun Lai ^a   Cai, Qi Yan ^a   Zhan, Xiao Li ^a   Xu, Yan ^a   Zhao, Shi Fu ^a   Yao, Zhong Xiang ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CUPRIZONE; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROGESTERONE; PROTEIN CC 1; TRANSCRIPTION FACTOR SOX10; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; CELL COUNT; CELL DEGENERATION; COGNITIVE DEFECT; CONTROLLED STUDY; DEMYELINATING DISEASE; DRUG MECHANISM; ELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NEUROPROTECTION; NICK END LABELING; NONHUMAN; OLIGODENDROGLIA; OPEN FIELD TEST; ROTAROD TEST;

ANIMALS; APOPTOSIS; BEHAVIOR, ANIMAL; BODY WEIGHT; CASPASE 3; CUPRIZONE; DEMYELINATING DISEASES; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, TRANSMISSION; OLIGODENDROGLIA; PROGESTERONE; ROTAROD PERFORMANCE TEST;

MUS;

EID: 84872858969     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054590     Document Type: Article

References (31)

1. Fancy SP, Kotter MR, Harrington EP, Huang JK, Zhao C, et al. (2010) Overcoming remyelination failure in multiple sclerosis and other myelin disorders. Exp Neurol 225: 18-23.
2. De Nicola AF, Labombarda F, Deniselle MC, Gonzalez SL, Garay L, et al. (2009) Progesterone neuroprotection in traumatic CNS injury and motoneuron degeneration. Front Neuroendocrinol 30: 173-187.
3. Franco-Pons N, Torrente M, Colomina MT, Vilella E, (2007) Behavioral deficits in the cuprizone-induced murine model of demyelination/remyelination. Toxicol Lett 169: 205-213.
4. Garay L, Deniselle MC, Lima A, Roig P, De Nicola AF, (2007) Effects of progesterone in the spinal cord of a mouse model of multiple sclerosis. J Steroid Biochem Mol Biol 107: 228-237.
5. Garay L, Deniselle MC, Meyer M, Costa JJ, Lima A, et al. (2009) Protective effects of progesterone administration on axonal pathology in mice with experimental autoimmune encephalomyelitis. Brain Res 1283: 177-185.
6. Garay L, Gonzalez Deniselle MC, Gierman L, Meyer M, Lima A, et al. (2008) Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis. Neuroimmunomodulation 15: 76-83.
7. Schumacher M, Guennoun R, Stein DG, De Nicola AF, (2007) Progesterone: therapeutic opportunities for neuroprotection and myelin repair. Pharmacol Ther 116: 77-106.
8. Stein DG, Wright DW, Kellermann AL, (2008) Does progesterone have neuroprotective properties? Ann Emerg Med 51: 164-172.
9. Ibanez C, Shields SA, El-Etr M, Baulieu EE, Schumacher M, et al. (2004) Systemic progesterone administration results in a partial reversal of the age-associated decline in CNS remyelination following toxin-induced demyelination in male rats. Neuropathol Appl Neurobiol 30: 80-89.
10. Koenig HL, Schumacher M, Ferzaz B, Thi AN, Ressouches A, et al. (1995) Progesterone synthesis and myelin formation by Schwann cells. Science 268: 1500-1503.
11. Labombarda F, Gonzalez SL, Lima A, Roig P, Guennoun R, et al. (2009) Effects of progesterone on oligodendrocyte progenitors, oligodendrocyte transcription factors, and myelin proteins following spinal cord injury. Glia 57: 884-897.
12. Garay L, Tungler V, Deniselle MC, Lima A, Roig P, et al. (2011) Progesterone attenuates demyelination and microglial reaction in the lysolecithin-injured spinal cord. Neuroscience 192: 588-597.
13. Ghoumari AM, Baulieu EE, Schumacher M, (2005) Progesterone increases oligodendroglial cell proliferation in rat cerebellar slice cultures. Neuroscience 135: 47-58.
14. Jung-Testas I, Schumacher M, Robel P, Baulieu EE, (1996) The neurosteroid progesterone increases the expression of myelin proteins (MBP and CNPase) in rat oligodendrocytes in primary culture. Cell Mol Neurobiol 16: 439-443.
15. Mason JL, Toews A, Hostettler JD, Morell P, Suzuki K, et al. (2004) Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions. Am J Pathol 164: 1673-1682.
16. Koenig HL, Gong WH, Pelissier P, (2000) Role of progesterone in peripheral nerve repair. Rev Reprod 5: 189-199.
17. Vukusic S, Ionescu I, El-Etr M, Schumacher M, Baulieu EE, et al. (2009) The Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple Sclerosis (POPART'MUS) trial: rationale, objectives and state of advancement. J Neurol Sci 286: 114-118.
18. Luoma JI, Kelley BG, Mermelstein PG, (2011) Progesterone inhibition of voltage-gated calcium channels is a potential neuroprotective mechanism against excitotoxicity. Steroids 76: 845-855.
19. Yates MA, Li Y, Chlebeck P, Proctor T, Vandenbark AA, et al. (2011) Progesterone treatment reduces disease severity and increases IL-10 in experimental autoimmune encephalomyelitis. J Neuroimmunol 220: 136-139.
20. Yu HJ, Fei J, Chen XS, Cai QY, Liu HL, et al. (2010) Progesterone attenuates neurological behavioral deficits of experimental autoimmune encephalomyelitis through remyelination with nucleus-sublocalized Olig1 protein. Neurosci Lett 476: 42-45.
21. Denic A, Johnson AJ, Bieber AJ, Warrington AE, Rodriguez M, et al. (2011) The relevance of animal models in multiple sclerosis research. Pathophysiology 18: 21-29.
22. Matsushima GK, Morell P, (2001) The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol 11: 107-116.
23. Kipp M, Norkus A, Krauspe B, Clarner T, Berger K, et al. (2011) The hippocampal fimbria of cuprizone-treated animals as a structure for studying neuroprotection in multiple sclerosis. Inflamm Res 60: 723-726.
24. Acs P, Kipp M, Norkute A, Johann S, Clarner T, et al. (2009) 17beta-estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice. Glia 57: 807-814.
25. Paxinos G, Franklin KBJ (2001) The Mouse Brain in Stereotoxic Coordinates, Second Edition, Academic Press, San Diego.
26. Stolt CC, Rehberg S, Ader M, Lommes P, Riethmacher D, et al. (2002) Terminal differentiation of myelin-forming oligodendrocytes depends on the transcription factor Sox10. Genes Dev 16: 165-170.
27. Hervey E, Hervey GR, (1967) The effects of progesterone on body weight and composition in the rat. J Endocrinol 37: 361-381.
28. Makinodan M, Yamauchi T, Tatsumi K, Okuda H, Takeda T, et al. (2009) Demyelination in the juvenile period, but not in adulthood, leads to long-lasting cognitive impairment and deficient social interaction in mice. Prog Neuropsychopharmacol Biol Psychiatry 33: 978-985.
29. Labombarda F, Gonzalez S, Lima A, Roig P, Guennoun R, et al. (2011) Progesterone attenuates astro- and microgliosis and enhances oligodendrocyte differentiation following spinal cord injury. Exp Neurol 231: 135-146.
30. Hesse A, Wagner M, Held J, Bruck W, Salinas-Riester G, et al. (2011) In toxic demyelination oligodendroglial cell death occurs early and is FAS independent. Neurobiol Dis 37: 362-369.
31. Copray JC, Kust BM, Mantingh-Otter I, Boddeke HW, (2005) p75NTR independent oligodendrocyte death in cuprizone-induced demyelination in C57BL/6 mice. Neuropathol Appl Neurobiol 31: 600-609.